Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Regeneus Ltd. ( (AU:CMB) ).
Cambium Bio Limited has announced a new issuance of 4,570,665 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX). This move is part of a previously announced transaction, indicating an expansion in the company’s capital base. The announcement could potentially impact the company’s market positioning by enhancing its financial flexibility and ability to pursue growth opportunities.
More about Regeneus Ltd.
Average Trading Volume: 15,250
Technical Sentiment Signal: Sell
Current Market Cap: A$6.58M
Find detailed analytics on CMB stock on TipRanks’ Stock Analysis page.